CD4 and Alzheimer disease: While no statistically significant difference in the number or fraction of Aβ, BACE1, CD3, CD4, CD45, and CD64 positive microvesicles was found, there was a trend towards a lower MFI of CD3 and CD4 in AD (Fig. 3).